
News|Articles|April 1, 2002
Reference pricing does not compromise outcomes of ACE inhibitor therapy
Concerns about possible unintended consequences of reference pricing-atleast when applied to ACE inhibitors-appear to be unfounded, according toa new analysis of Canadian data.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























